Relief Therapeutics (OTCMKTS:RLFTF) Stock Price Down 5.5% – Here’s What Happened

Relief Therapeutics Holding SA (OTCMKTS:RLFTF)’s share price fell 5.5% during trading on Friday . The stock traded as low as $0.9123 and last traded at $0.9123. 3,634 shares changed hands during mid-day trading, an increase of 63% from the average session volume of 2,235 shares. The stock had previously closed at $0.9650.

Relief Therapeutics Stock Performance

The firm has a 50-day moving average price of $1.76 and a two-hundred day moving average price of $2.93.

About Relief Therapeutics

Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.